These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1824566)

  • 1. Drug eruptions: a review of clinical and immunological features.
    Kalish RS
    Adv Dermatol; 1991; 6():221-37; discussion 238. PubMed ID: 1824566
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased frequencies of Th17 cells in drug eruptions.
    Fujiyama T; Kawakami C; Sugita K; Kubo-Kabashima R; Sawada Y; Hino R; Nakamura M; Shimauchi T; Ito T; Kabashima K; Hashizume H; Tokura Y
    J Dermatol Sci; 2014 Jan; 73(1):85-8. PubMed ID: 24035443
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct immunofluorescence for the study of cutaneous drug eruptions.
    Gibson LE; van Hale HM; Schroeter AL
    Acta Derm Venereol; 1986; 66(1):39-44. PubMed ID: 2424213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruption. A brief review.
    Korkij W; Soltani K
    Arch Dermatol; 1984 Apr; 120(4):520-4. PubMed ID: 6231004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.
    Shiohara T; Mizukawa Y
    Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mononuclear-macrophages are predominantly classically activated in aminopenicillin-induced maculopapular rashes.
    Treudler R; Tebbe B; Mielcarek K; Goerdt S; Orfanos CE
    Arch Dermatol Res; 2002 Aug; 294(6):290-2. PubMed ID: 12192494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of drug exanthema].
    Bjerke JR
    Tidsskr Nor Laegeforen; 1984 Nov; 104(33):2326-8, 39. PubMed ID: 6240799
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug hypersensitivity: insights into pathomechanisms.
    Martin E; Mayorga C; Rodriguez R; Torres MJ; Blanca M
    Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):207-12. PubMed ID: 16156398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and histological features of cutaneous drug reactions].
    Collet E; Touraud JP; Justrabo E; Ponnelle T; Sgro C; Lambert D
    Therapie; 2002; 57(3):254-6. PubMed ID: 12422536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [145 cases of toxidermatoses. Clinical, histologic and immunologic study].
    Saurat JH; Puissant A; Tilles G; Noury-Duperrat G; Duperrat B
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):666-9. PubMed ID: 137687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitization to phenacetin: immunological aspects].
    Rüegger R; Spengler H; de Weck AL; Dubach UC
    Dtsch Med Wochenschr; 1973 Apr; 98(15):762-4 passim. PubMed ID: 4266644
    [No Abstract]   [Full Text] [Related]  

  • 12. [Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
    Barbaud A; Reichert-Pénétrat S; Béné MC; Kolopp-Sarda MN; Faure G; Kohler C; Schmutz JL
    Ann Dermatol Venereol; 2000; 127(6-7):662-3. PubMed ID: 11041825
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring the acute phase response in non-immediate allergic drug reactions.
    Mayorga C; Pena RR; Blanca-López N; López S; Martin E; Torres MJ
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):249-57. PubMed ID: 16825864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced lupus secondary to sertraline.
    Hussain HM; Zakaria M
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1074-5. PubMed ID: 19031644
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
    Yanase K; Imamura S
    Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The skin as an indicator of potential anaphylactoid reactions.
    Gowland G
    Ann Fr Anesth Reanim; 1985; 4(2):173-5. PubMed ID: 3159317
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous drug eruptions: a 5-year experience.
    Gerson D; Sriganeshan V; Alexis JB
    J Am Acad Dermatol; 2008 Dec; 59(6):995-9. PubMed ID: 19022101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects and immunochemistry of allergic reactions of the respiratory system and the skin].
    Findeisen DG
    Allerg Asthma (Leipz); 1969; 15(3):182-95. PubMed ID: 4190084
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced CD30+ T cell pseudolymphoma.
    Fukamachi S; Sugita K; Sawada Y; Bito T; Nakamura M; Tokura Y
    Eur J Dermatol; 2009; 19(3):292-4. PubMed ID: 19336342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphocyte transformation test in the drug eruptions--the significance of cutaneous fractions as carrier (author's transl)].
    Suzuki S; Asai Y; Hamada T; Mizoguchi Y; Yamada T
    Nihon Hifuka Gakkai Zasshi; 1977 Aug; 87(9):531-5. PubMed ID: 144200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.